Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission TomographyMartin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
Bioorganic & Medicinal Chemistry|September 12, 2016
Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[<sup>18</sup>F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6'-[<sup>18</sup>F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxiaThomas Wanek, Katharina Kreis, Petra Križková, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Brain : a Journal of Neurology|November 29, 2011
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema, Mark Lubberink, Martin Bauer, et al.
The Lancet. Neurology|June 22, 2013
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control studyMaria Feldmann, Marie-Claude Asselin, Joan Liu, et al.
Molecular Pharmacology|February 20, 2016
Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse ModelShannon Dallas, Laurent Salphati, David Gomez-Zepeda, et al.
Journal of Medicinal Chemistry|July 11, 2015
Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission TomographyKerstin Sander, Eva Galante, Thibault Gendron, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission TomographyMartin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
Bioorganic & Medicinal Chemistry|September 12, 2016
Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[<sup>18</sup>F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6'-[<sup>18</sup>F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxiaThomas Wanek, Katharina Kreis, Petra Križková, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Brain : a Journal of Neurology|November 29, 2011
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema, Mark Lubberink, Martin Bauer, et al.
The Lancet. Neurology|June 22, 2013
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control studyMaria Feldmann, Marie-Claude Asselin, Joan Liu, et al.
Molecular Pharmacology|February 20, 2016
Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse ModelShannon Dallas, Laurent Salphati, David Gomez-Zepeda, et al.
Journal of Medicinal Chemistry|July 11, 2015
Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission TomographyKerstin Sander, Eva Galante, Thibault Gendron, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 16